NewsRx

Search our medical news database

AIDS Vaccines

Protection, HIV Clearance with rgp120 ISCOM

Published in Vaccine Weekly, May 17th, 1999

Immune-stimulating complexes (ISCOMs) are the best way to formulate HIV envelope antigens, a comparative trial shows.

A Dutch/Swedish/U.S. research team compared T-helper immune responses in groups of rhesus macaque monkeys given one of three different envelope-based HIV vaccines. The vaccines used the HIV-1SF2 gp120 envelope glycoprotein expressed in vivo via DNA immunization (gene-gun administered); delivered as a subunit protein with MF59 adjuvant; or incorporated into ISCOMs.

"The best immune response to the gp120SF2 antigen was obtained by incorporating this antigen into ISCOMs," reported Ernst. J. Verschoor of the...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook